Free Subscription

  • Access daily briefings and unlimited news articles

Premium

Only $39.95 per year
  • Quarterly magazine and digital
  • Indepth executive interviews
  • Unlimited news and insights
  • Expert opinion and analysis

OneTouch

OneTouch Archives

Johnson & Johnson sells LifeScan for $2.1bn

FMCG giant will still continue to create products for consumers with diabetes.

Johnson & Johnson receives $2 billion offer to acquire LifeScan, Inc.

LifeScan manufactures blood glucose monitoring products.